415 related articles for article (PubMed ID: 29978303)
21. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
Weber S; Scheich S; Magh A; Wolf S; Enßle JC; Brunnberg U; Reinheimer C; Wichelhaus TA; Kempf VAJ; Kessel J; Vehreschild MJGT; Serve H; Bug G; Steffen B; Hogardt M
Int J Infect Dis; 2020 Oct; 99():428-436. PubMed ID: 32798661
[TBL] [Abstract][Full Text] [Related]
22. The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study.
Ramanathan M; Kim S; He N; Chen M; Hematti P; Abid MB; Rotz SJ; Williams KM; Lazarus HM; Wirk B; Yin DE; Kanakry CG; Perales MA; Chemaly RF; Dandoy CE; Riches M; Ustun C
Bone Marrow Transplant; 2023 Apr; 58(4):360-366. PubMed ID: 36543999
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study.
Styczynski J; Czyzewski K; Wysocki M; Gryniewicz-Kwiatkowska O; Kolodziejczyk-Gietka A; Salamonowicz M; Hutnik L; Zajac-Spychala O; Zaucha-Prazmo A; Chelmecka-Wiktorczyk L; Siewiera K; Fraczkiewicz J; Malas Z; Tomaszewska R; Irga-Jaworska N; Plonowski M; Ociepa T; Pierlejewski F; Gamrot Z; Urbanek-Dadela A; Gozdzik J; Stolpa W; Dembowska-Baginska B; Perek D; Matysiak M; Wachowiak J; Kowalczyk J; Balwierz W; Kalwak K; Chybicka A; Badowska W; Szczepanski T; Drozynska E; Krawczuk-Rybak M; Urasinski T; Mlynarski W; Woszczyk M; Karolczyk G; Sobol-Milejska G; Gil L;
Clin Microbiol Infect; 2016 Feb; 22(2):179.e1-179.e10. PubMed ID: 26493843
[TBL] [Abstract][Full Text] [Related]
24. Investigation of Clostridium difficile ribotypes in symptomatic patients of a German pediatric oncology center.
Simon A; Mock M; Graf N; von Müller L
Eur J Pediatr; 2018 Mar; 177(3):403-408. PubMed ID: 29273940
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
[TBL] [Abstract][Full Text] [Related]
26. Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission.
Al-Rawahi GN; Al-Najjar A; McDonald R; Deyell RJ; Golding GR; Brant R; Tilley P; Thomas E; Rassekh SR; O'Gorman A; Wong P; Turnham L; Dobson S
Pediatr Blood Cancer; 2019 May; 66(5):e27604. PubMed ID: 30666782
[TBL] [Abstract][Full Text] [Related]
27. Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
Lo Vecchio A; Lancella L; Tagliabue C; De Giacomo C; Garazzino S; Mainetti M; Cursi L; Borali E; De Vita MV; Boccuzzi E; Castellazzi L; Esposito S; Guarino A
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):177-185. PubMed ID: 27696233
[TBL] [Abstract][Full Text] [Related]
28. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
[TBL] [Abstract][Full Text] [Related]
29. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
[TBL] [Abstract][Full Text] [Related]
30. Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study.
Salamonowicz-Bodzioch M; Frączkiewicz J; Czyżewski K; Zając-Spychała O; Gorczyńska E; Wróbel G; Kazanowska B; Sęga-Pondel D; Węcławek-Tompol J; Ussowicz M; Kałwak K; Wysocki M; Dziedzic M; Wachowiak J; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Styczyński J
Ann Hematol; 2022 Jan; 101(1):191-201. PubMed ID: 34674000
[TBL] [Abstract][Full Text] [Related]
31. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.
Ciricillo J; Haslam D; Blum S; Kim MO; Liu C; Paulsen G; Courter J; Danziger-Isakov L
Transpl Infect Dis; 2016 Oct; 18(5):706-713. PubMed ID: 27492796
[TBL] [Abstract][Full Text] [Related]
32. Risk factors, preemptive therapy, and antiperistaltic agents for Clostridium difficile infection in cancer patients.
Krishna SG; Zhao W; Apewokin SK; Krishna K; Chepyala P; Anaissie EJ
Transpl Infect Dis; 2013 Oct; 15(5):493-501. PubMed ID: 24034141
[TBL] [Abstract][Full Text] [Related]
33. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
Kinnebrew MA; Lee YJ; Jenq RR; Lipuma L; Littmann ER; Gobourne A; No D; van den Brink M; Pamer EG; Taur Y
PLoS One; 2014; 9(3):e90158. PubMed ID: 24662889
[TBL] [Abstract][Full Text] [Related]
34. Community-acquired Clostridium difficile infection in Serbian pediatric population.
Predrag S; Branislava K; Nikola S; Niko R; Zorica SR; Stanković-Đorđević D
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1061-1069. PubMed ID: 29497879
[TBL] [Abstract][Full Text] [Related]
35. Risk Factors for Recurrent Clostridium difficile Infection in Pediatric Inpatients.
Schwab EM; Wilkes J; Korgenski K; Hersh AL; Pavia AT; Stevens VW
Hosp Pediatr; 2016 Jun; 6(6):339-44. PubMed ID: 27146969
[TBL] [Abstract][Full Text] [Related]
36. Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes.
Ford CD; Lopansri BK; Coombs J; Webb BJ; Nguyen A; Asch J; Hoda D
Clin Transplant; 2019 Nov; 33(11):e13712. PubMed ID: 31532030
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study.
Selvey LA; Slimings C; Joske DJ; Riley TV
PLoS One; 2016; 11(6):e0157839. PubMed ID: 27314498
[TBL] [Abstract][Full Text] [Related]
39. Risk factors and impact of Clostridium difficile recurrence on haematology patients.
Scappaticci GB; Perissinotti AJ; Nagel JL; Bixby DL; Marini BL
J Antimicrob Chemother; 2017 May; 72(5):1488-1495. PubMed ID: 28186243
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients.
Mani S; Rybicki L; Jagadeesh D; Mossad SB
Bone Marrow Transplant; 2016 May; 51(5):713-7. PubMed ID: 26726944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
